Neimeth International Pharmaceuticals Board Meeting Oct 2026

Neimeth International Pharmaceuticals Plc has filed a board meeting notice with the Nigerian Exchange Limited, dated 14th October 2026. The board of directors is scheduled to convene on Tuesday, 27th October 2026, to consider and approve the company's unaudited financial statements for the period ended 30th September 2026, referred to in the filing as the 2026 Q3 UFS.

In accordance with NGX's Amended Closed Period Rules, Neimeth commenced a closed period from 1st October 2026. This closed period will remain in effect until twenty-four hours after the outcome of the board meeting and the release of the Q3 unaudited financial statements to the public.

The company has notified its directors and other insiders of the restriction on dealing in the company's securities for the duration of the closed period. The filing was signed by Chinenye S. Adekanmbi, the company secretary. No financial figures or performance details were disclosed in this notice. The actual results will only be available following the board meeting and their subsequent public release.